U.S. Markets open in 50 mins.

Pfizer Inc. (PFE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.05-0.09 (-0.28%)
At close: 4:00PM EDT
People also watch
MRKJNJJPMGEINTC
Interactive chart
Previous Close32.14
Open32.17
Bid31.99 x 1300
Ask32.05 x 300
Day's Range31.97 - 32.28
52 Week Range29.83 - 37.39
Volume22,486,949
Avg. Volume22,179,312
Market Cap191.27B
Beta1.04
PE Ratio (TTM)27.32
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.99%)
Ex-Dividend Date2017-02-01
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters29 minutes ago

    Drug approvals bounce back as R&D labs churn out new winners

    The U.S. Food and Drug Administration has already cleared 21 new prescription medicines for sale against 22 in the whole of 2016, and just nine at this stage last year. The European Medicines Agency has recommended 42 compared with a 2016 total of 81, and 31 in the first five months of last year. Unlike the FDA, the EMA includes generic or non-patented drugs in its list.

  • Market Realist1 hour ago

    Merck’s Immunology and Cardiovascular Franchise in 1Q17

    Remicade, a top-selling drugs for the treatment of inflammatory disorders, is losing market share after the loss of exclusivity in European markets in February 2015.

  • Market Realist22 hours ago

    Performance of Merck’s Diabetes Portfolio in 1Q17

    Combined sales for Januvia and Janumet were ~$1.3 billion for 1Q17, a ~5.0% fall from $1.4 billion in 1Q16.